Fifteen unselected patients who had essential hypertension and whose average supine blood pressure when they were not receiving any treatment and their usual sodium intake was 162/ 107 mm Hg were treated with captopril 50 mg twice daily. After one month's treatment their supine blood pressure had decreased to 149/94 mm Hg. They were then instructed to reduce their sodium intake to about 80 mmol(mEq)/day. After two weeks of moderate sodium restriction they were entered into a double blind randomised crossover study comparing the effect of 10 Slow Sodium tablets (100 mmol sodium chloride) with matching placebo tablets while continuing to take captopril and restrict sodium in their diet. After one month of taking placebo their mean supine blood pressure was 137/88 mm Hg with a urinary sodium excretion of 83 mmol/24 h, while after one month of taking Slow Sodium tablets their mean supine blood pressure was 150/97 mm Hg (p<0001) with a sodium excretion of 183 mmoll24 h. The mean supine blood pressure during moderate sodium restriction therefore decreased by 9% and correlated significantly with the reduction in urinary sodium excretion.
Introduction
The effectiveness of moderate sodium restriction alone in decreasing blood pressure in patients with mild to moderate essential hypertension is controversial,' owing at least partly to the finding that the decrease in blood pressure under such conditions is related to the severity of hypertension. Thus patients with borderline or mild hypertension may show no or only a small decrease in blood pressure.' This differing response seems to be related to a blunting of renin responsiveness to sodium restriction as high blood pressure becomes more severe.34 In other words patients showing the smallest decrease in blood pressure had the greatest increase in renin concentrations,' which offset the decrease in blood pressure, and angiotensin II.
The angiotensin converting enzyme inhibitors block the enzyme responsible for the conversion of angiotensin I to angiotensin I1. 6 This leads to a decrease in angiotensin II production and thereby a decrease in blood pressure.7 In many patients who have untreated essential hypertension and whose sodium intake is normal, however, renin and angiotensin II are below normal and the decrease in blood pressure that occurs with converting enzyme inhibition is less than that in patients with higher renin activity. 89 Theoretically then the combination of moderate sodium restriction and an angiotensin enzyme inhibitor should overcome the disadvantages of both treatments given alone. We therefore conducted a study of moderate sodium restriction in patients who had mild to moderate essential hypertension and who were already being treated with captopril. The alteration in the diet was performed in a double blind manner by using Slow Sodium tablets and matching placebo.
Patients and methods
Patients were referred by local general practitioners to the blood pressure unit. We had observed those participating in the trial for several months before entry to the trial. No 
Results
The table shows the changes in blood pressure, renin activity, other blood and urinary measurements, and weight during the study. Figure 1 summarises the changes in blood pressure and urinary sodium excretion. Figure 2 shows the difference between the blood pressures of subjects in their fourth week of taking Slow Sodium tablets and that in their fourth week of taking placebo. Thirteen patients showed a decrease in blood pressure, one patient showed no change, and one patient had a slight Watt et al performed a double blind trial with a similar protocol to our own that showed that sodium restriction had no effect on blood pressure. '5 In the study of Watt et al, however, when patients were receiving their "normal" sodium intake-that is, Slow Sodium tablets-the mean supine blood pressure was in the normal range, at 136/83 mm Hg. '5 When most studies of dietary salt restriction alone are considered the blood pressure of people with milder hypertension is less affected by salt restriction,2 and normotensive subjects show little or no decrease in blood pressure.2 This seems to be related to a greater increase in renin activity and angiotensin II concentration in people with lower initial blood pressure, which offsets the decrease in blood pressure that would have occurred during salt restriction.35 A converting enzyme inhibitor, by reducing the formation of angiotensin II in spite of the increased renin activity, blocks this compensatory response so that blood pressure is much more dependent on changes in sodium and water balance. This concept is supported by the finding in our study that the decrease in blood pressure when sodium intake was reduced was directly related to the reduction in urinary sodium excretion and to the weight loss and increase in plasma albumin concentration that occurred. The lack of relation between the severity of the blood pressure and the decrease in blood pressure in our study suggests that once the renin system is blocked sodium restriction is then effective, even in patients with milder or borderline hypertension. Angiotensin converting enzyme inhibitors alone do not usually control blood pressure, particularly in patients with more moderate hypertension. The addition of a diuretic has been advocated and shown to have an additive effect.16'7 The metabolic effects of thiazide diuretics also seem to be lessened by the addition of a converting enzyme inhibitor.' Nevertheless, even in this latter study when Weinberger combined treatment of a diuretic and captopril there was still a significant decrease in plasma potassium concentration and an increase in urate concentration.' We did not compare directly the effectiveness of moderate salt restriction and captopril against that of a thiazide diuretic and captopril. The decrease in blood pressure with salt restriction in our study, however, seems to be similar to that found when a diuretic has been added to captopril. 16 7 An important advantage of salt restriction over diuretics is that moderate salt restriction causes few or no metabolic side effects, in particular no decrease in plasma potassium concentration.
Compliance with long term moderate sodium restriction could be a problem in the widespread use ofcombined treatment ofmoderate salt restriction and converting enzyme inhibitors. Our own experience in patients who have now restricted moderately their salt intake for some years-that is, reduced it to about 80 mmol/day-has shown that they have little difficulty in sticking to this sort of diet provided that they eat at home, a finding similar to that of Thaler et al in New Zealand.'8 Long term compliance is helped by the fact that once patients have overcome the first few weeks ofthe change in the diet, in which food may taste bland, salt sensitivity of the taste receptors in the mouth changes.'9 Most patients then find that the foods with a high salt content that they used to like are unpleasant and much prefer foods with less salt. Our results also suggest that once the formation of angiotensin II is blocked more severe sodium restriction would be even more effective in decreasing blood pressure. For patients to reduce sodium intake below 80 mmol/day, however, requires the provision of special foods, particularly salt free bread, that are not yet generally available in the United Kingdom and the avoidance of most processed foods.
We think that in patients with mild to moderate essential hypertension who are prepared moderately to reduce their sodium intake such a reduction, together with other non-pharmacological advice, should be the first step in their management. If this fails to control their blood pressure additional treatment with an angiotensin converting enzyme inhibitor such as captopril is particularly effective. This approach overcomes the objections oflack ofefficacy that have been made both against moderate salt restriction alone and converting enzyme inhibition alone.
Are we drinking our neurones away? CLIVE HARPER, JILLIAN KRIL, JOHN DALY Abstract A quantitative neuropathological necropsy study of the human cerebral cortex showed that the number of cortical neurones in the superior frontal cortex in chronic alcoholic patients is significantly reduced compared with that in controls matched for age and sex. The number ofneurones in the motor cortex did not differ significantly between the controls and alcoholics, but in both cortical regions there was evidence that alcoholic patients had smaller (shrunken) neurones than controls.
Further studies are necessary to identify other regions of the cerebral cortex that are selectively damaged in brain damage associated with alcohol. Introduction Alcoholic beverages have been available in almost every civilisation known to man. Today, particularly in Western countries, they are an accepted part of society.
The popular belief that excessive alcohol (ethanol) intake, particularly "binge" drinking, causes damage to nerve cells and death in the cerebral cortex is not based on any reliable scientific data. Pathologists have commented on a "patchy loss of cortical neurones" in the brains of alcoholic patients,' but this has not been quantified, and similar subjective observations in other diseases have often been shown to be invalid. There are experimental data, however, that show a loss of neurones in animal models of chronic alcohol intoxication.2 In a recent collaborative study we documented the loss of neurones in the cerebellar vermis of alcoholics. 3 With regard to the cerebral cortex neuroradiological evidence shows that chronic alcoholic patients4 and even heavy social drinkers5 suffer from brain "shrinkage," and there is some correlation between this change and clinical and neuropsychological deficiencies. In recent quantitative neuropathological studies we have shown that the weights of the brains of chronic alcoholics are significantly reduced6 and that the pericerebral space (the space between the brain and the skull) is increased.7 Stereometric measurements of the volumes of cortical grey matter, white matter, and basal ganglia in the brains ofcontrols and alcoholics have shown that the loss of cerebral tissue in alcoholics is largely from the white matter.8 This shrinkage of white matter could be caused by loss of neurones with subsequent degeneration of axons. The purpose of this study was to investigate such a hypothesis.
